Literature DB >> 20739516

NS reassortment of an H7-type highly pathogenic avian influenza virus affects its propagation by altering the regulation of viral RNA production and antiviral host response.

Zhongfang Wang1, Nicole C Robb, Eva Lenz, Thorsten Wolff, Ervin Fodor, Stephan Pleschka.   

Abstract

Highly pathogenic avian influenza viruses (HPAIV) with reassorted NS segments from H5- and H7-type avian virus strains placed in the genetic background of the A/FPV/Rostock/34 HPAIV (FPV; H7N1) were generated by reverse genetics. Virological characterizations demonstrated that the growth kinetics of the reassortant viruses differed from that of wild-type (wt) FPV and depended on whether cells were of mammalian or avian origin. Surprisingly, molecular analysis revealed that the different reassortant NS segments were not only responsible for alterations in the antiviral host response but also affected viral genome replication and transcription as well as nuclear ribonucleoprotein (RNP) export. RNP reconstitution experiments demonstrated that the effects on accumulation levels of viral RNA species were dependent on the specific NS segment as well as on the genetic background of the RNA-dependent RNA polymerase (RdRp). Beta interferon (IFN-β) expression and the induction of apoptosis were found to be inversely correlated with the magnitude of viral growth, while the NS allele, virus subtype, and nonstructural protein NS1 expression levels showed no correlation. Thus, these results demonstrate that the origin of the NS segment can have a dramatic effect on the replication efficiency and host range of HPAIV. Overall, our data suggest that the propagation of NS reassortant influenza viruses is affected at multiple steps of the viral life cycle as a result of the different effects of the NS1 protein on multiple viral and host functions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20739516      PMCID: PMC2953208          DOI: 10.1128/JVI.01034-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

1.  A recombinant influenza A virus expressing an RNA-binding-defective NS1 protein induces high levels of beta interferon and is attenuated in mice.

Authors:  Nicola R Donelan; Christopher F Basler; Adolfo García-Sastre
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

Review 2.  Intracellular warfare between human influenza viruses and human cells: the roles of the viral NS1 protein.

Authors:  Robert M Krug; Weiming Yuan; Diana L Noah; Anita Ghate Latham
Journal:  Virology       Date:  2003-05-10       Impact factor: 3.616

3.  RIG-I detects viral genomic RNA during negative-strand RNA virus infection.

Authors:  Jan Rehwinkel; Choon Ping Tan; Delphine Goubau; Oliver Schulz; Andreas Pichlmair; Katja Bier; Nicole Robb; Frank Vreede; Wendy Barclay; Ervin Fodor; Caetano Reis e Sousa
Journal:  Cell       Date:  2010-02-05       Impact factor: 41.582

4.  Influenza virus propagation is impaired by inhibition of the Raf/MEK/ERK signalling cascade.

Authors:  S Pleschka; T Wolff; C Ehrhardt; G Hobom; O Planz; U R Rapp; S Ludwig
Journal:  Nat Cell Biol       Date:  2001-03       Impact factor: 28.824

5.  Sequence of the 1918 pandemic influenza virus nonstructural gene (NS) segment and characterization of recombinant viruses bearing the 1918 NS genes.

Authors:  C F Basler; A H Reid; J K Dybing; T A Janczewski; T G Fanning; H Zheng; M Salvatore; M L Perdue; D E Swayne; A García-Sastre; P Palese; J K Taubenberger
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

6.  Influenza A virus NS2 protein mediates vRNP nuclear export through NES-independent interaction with hCRM1.

Authors:  G Neumann; M T Hughes; Y Kawaoka
Journal:  EMBO J       Date:  2000-12-15       Impact factor: 11.598

7.  The 3'-end-processing factor CPSF is required for the splicing of single-intron pre-mRNAs in vivo.

Authors:  Y Li; Z Y Chen; W Wang; C C Baker; R M Krug
Journal:  RNA       Date:  2001-06       Impact factor: 4.942

8.  Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication.

Authors:  M Bergmann; A Garcia-Sastre; E Carnero; H Pehamberger; K Wolff; P Palese; T Muster
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

9.  Effects of influenza A virus NS1 protein on protein expression: the NS1 protein enhances translation and is not required for shutoff of host protein synthesis.

Authors:  Mirella Salvatore; Christopher F Basler; Jean-Patrick Parisien; Curt M Horvath; Svetlana Bourmakina; Hongyong Zheng; Thomas Muster; Peter Palese; Adolfo García-Sastre
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

10.  Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands.

Authors:  Marion Koopmans; Berry Wilbrink; Marina Conyn; Gerard Natrop; Hans van der Nat; Harry Vennema; Adam Meijer; Jim van Steenbergen; Ron Fouchier; Albert Osterhaus; Arnold Bosman
Journal:  Lancet       Date:  2004-02-21       Impact factor: 79.321

View more
  20 in total

1.  The influenza A virus NS1 protein interacts with the nucleoprotein of viral ribonucleoprotein complexes.

Authors:  Nicole C Robb; Geoffrey Chase; Katja Bier; Frank T Vreede; Pang-Chui Shaw; Nadia Naffakh; Martin Schwemmle; Ervin Fodor
Journal:  J Virol       Date:  2011-03-16       Impact factor: 5.103

2.  Double-stranded RNA-induced activation of activating protein-1 promoter is differentially regulated by the non-structural protein 1 of avian influenza A viruses.

Authors:  Muhammad Munir; Siamak Zohari; Sándor Belák; Mikael Berg
Journal:  Viral Immunol       Date:  2012-01-12       Impact factor: 2.257

3.  Activation of c-jun N-terminal kinase upon influenza A virus (IAV) infection is independent of pathogen-related receptors but dependent on amino acid sequence variations of IAV NS1.

Authors:  Wolfgang Nacken; Darisuren Anhlan; Eike R Hrincius; Ahmed Mostafa; Thorsten Wolff; Anne Sadewasser; Stephan Pleschka; Christina Ehrhardt; Stephan Ludwig
Journal:  J Virol       Date:  2014-05-28       Impact factor: 5.103

Review 4.  Implications of segment mismatch for influenza A virus evolution.

Authors:  Maria C White; Anice C Lowen
Journal:  J Gen Virol       Date:  2017-12-15       Impact factor: 3.891

5.  Reassortment of NS segments modifies highly pathogenic avian influenza virus interaction with avian hosts and host cells.

Authors:  Henning Petersen; Zhongfang Wang; Eva Lenz; Stephan Pleschka; Silke Rautenschlein
Journal:  J Virol       Date:  2013-03-06       Impact factor: 5.103

6.  Mutations in the M-gene segment can substantially increase replication efficiency of NS1 deletion influenza A virus in MDCK cells.

Authors:  R van Wielink; M M Harmsen; D E Martens; B P H Peeters; R H Wijffels; R J M Moormann
Journal:  J Virol       Date:  2012-09-05       Impact factor: 5.103

7.  The non-structural (NS) gene segment of H9N2 influenza virus isolated from backyard poultry in Pakistan reveals strong genetic and functional similarities to the NS gene of highly pathogenic H5N1.

Authors:  Muhammad Munir; Siamak Zohari; Munir Iqbal; Muhammad Abbas; Daniel Roberto Perez; Mikael Berg
Journal:  Virulence       Date:  2013-08-13       Impact factor: 5.882

8.  An influenza reassortant with polymerase of pH1N1 and NS gene of H3N2 influenza A virus is attenuated in vivo.

Authors:  Holly Shelton; Matt Smith; Lorian Hartgroves; Peter Stilwell; Kim Roberts; Ben Johnson; Wendy Barclay
Journal:  J Gen Virol       Date:  2012-02-08       Impact factor: 3.891

9.  The RNA-binding domain of influenzavirus non-structural protein-1 cooperatively binds to virus-specific RNA sequences in a structure-dependent manner.

Authors:  Daniel Marc; Sosthène Barbachou; Denis Soubieux
Journal:  Nucleic Acids Res       Date:  2012-10-23       Impact factor: 16.971

10.  Replication and adaptive mutations of low pathogenic avian influenza viruses in tracheal organ cultures of different avian species.

Authors:  Henning Petersen; Mikhail Matrosovich; Stephan Pleschka; Silke Rautenschlein
Journal:  PLoS One       Date:  2012-08-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.